The role of B7-1 and B7-2 costimulation for the generation of CTL responses in vivo

Journal of Immunology

Volumn 161, Issue 6, 1998, Pages 2740-2745

  Sigal, Luis J ^a   Reiser, Hans ^b   Rock, Kenneth L ^a  

^a UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^b HAMMERSMITH HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGEN PRESENTATION; ANTIGEN PRESENTING CELL; ARTICLE; CYTOTOXIC T LYMPHOCYTE; IMMUNOMODULATION; IMMUNOREGULATION; LYMPHOCYTE ACTIVATION; PRIORITY JOURNAL; REGULATORY MECHANISM;

ANIMALS; ANTIBODIES, BLOCKING; ANTIGEN-PRESENTING CELLS; ANTIGENS, CD; ANTIGENS, CD80; ANTIGENS, CD86; ANTIGENS, VIRAL; CELL LINE; CYTOTOXICITY, IMMUNOLOGIC; FEMALE; IMMUNE SERA; INJECTIONS, SUBCUTANEOUS; LYMPHOCYTE ACTIVATION; MEMBRANE GLYCOPROTEINS; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MICROSPHERES; OVALBUMIN; STEM CELLS; T-LYMPHOCYTES, CYTOTOXIC; VACCINIA VIRUS;

EID: 0032530535     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (45)

1. Germain, R. N., and D. H. Margulies. 1993. The biochemistry and cell biology of antigen processing and presentation. Annu. Rev. Immunol. 11:403.
2. Rock, K. L. 1996. A new foreign policy: MHC class I molecules monitor the outside world. Immunol. Today 17:13.
3. Boussiotis, V. A., G. J. Freeman, J. G. Gribben, and L. M. Nadler. 1996. The role of B7-1/B7-2:CD28/CTLA-4 pathways in the prevention of anergy, induction of productive immunity, and down-regulation of the immune response. Immunol. Rev. 153:5.
4. Van Gool, S. W., P. Vandenberghe, M. de Boer, and J. L. Ceuppens. 1996. CD80, CD86, and CD40 provide accessory signals in a multiple-step T-cell activation model. Immunol. Rev. 153:47.
5. Lafferty, K. J., and A. J. Cunningham. 1975. A new analysis of allogeneic interactions. Aust. J. Exp. Biol. Med. Sci. 53:27.
6. Boussiotis, V. A., J. G. Gribben, G. J. Freeman, and L. M. Nadler. 1994. Blockade of the CD28 co-stimulatory pathway: a means to induce tolerance. Curr. Opin. Immunol. 6:797.
7. Germain, R. N. 1986. The ins and outs of antigen processing and presentation. Nature 332:687.
8. Cresswell, P. 1990. Immunology: questions of presentation. Nature 343:593.
9. Chambers, C. A., M. F. Krummel, B. Boitel, A. Hurwitz, T. J. Sullivan, S. Fournier, D. Cassell, M. Brunner, and J. P. Allison. 1996. The role of CTLA-4 in the regulation and initiation of T-cell responses. Immunol. Rev. 153:27.
10. Matzinger, P. 1994. Tolerance, danger, and the extended family. Annu. Rev. Immunol. 12:991.
11. Plate, J. 1976. Soluble factors substitute for T-T-cell collaboration in generation of T-killer lymphocytes. Nature 260:329.
12. Wagner, H., C. Hardt, K. Heeg, K. Pfizenmaier, W. Solbach, R. Bartlett, H. Stockinger, and M. Rollinghoff. 1980. T-T cell interactions during cytotoxic T lymphocyte (CTL) responses: T cell-derived helper factor (interleukin 2) as a probe to analyze CTL responsiveness and thymic maturation of CTL progenitors. Immunol. Rev. 51:215.
13. Ashman, R., and A. Mullbacher. 1979. A helper cell for antiviral cytotoxic T cell responses. J. Exp. Med. 150:1277.
14. von Boehmer, H., and W. Haas. 1979. Distinct Ir genes for helper and killer cells in the cytotoxic response to H-Y antigen. J. Exp. Med. 150:1134.
15. Keene, J., and J. Forman. 1982. Helper activity is required for the in vivo generation of cytotoxic T lymphocytes. J. Exp. Med. 155:768.
16. + T cell subsets in the control of an acute herpes simplex virus infection of the skin and nervous system. J. Gen. Viral. 68:825.
17. Buller, R., K. Holmes, A. Hugin, T. Frederickson, and H. D. Morse. 1987. Induction of cytotoxic T-cell responses in vivo in the absence of CD4 helper cells. Nature 328:77.
18. + T helper cell function in vivo: differential requirement for induction of antiviral cytotoxic T-cell and antibody responses. J. Virol. 62:2102.
19. Bodmer, H., G. Obert, S. Chan, C. Benoist, and D. Mathis. 1993. Environmental modulation of the autonomy of cytotoxic T lymphocytes. Eur. J. Immunol. 23: 1649.
20. Rock, K. L., and K. Clark. 1996. Analysis of the role of MHC class II presentation in the stimulation of CTLs by antigens targeted into the exogenous antigen-MHC class I presentation pathway. J. Immunol. 156:3721.
21. + cytotoxic T lymphocytes in the absence of exogenous help. J. Exp. Med. 177:1791.
22. Guerder, S., and P. Matzinger. 1992. A fail-safe mechanism for maintaining self-tolerance. J. Exp. Med. 176:553.
23. + T cells in vitro. J. Exp. Med. 183:2247.
24. + T cells. J. Immunol. 157: 3250.
25. + T cells by B7-transfected melanoma cells. Science 259:368.
26. Huang, A. Y., A. T. Bruce, D. M. Pardoll, and H. I. Levitsky. 1996. Does B7-1 expression confer antigen-presenting cell capacity to tumors in vivo? J. Exp. Med. 183:769.
27. Wu, T. C., A. Y. Huang, E. M. Jaffee, H. I. Levitsky, and D. M. Pardoll. 1995. A reassessment of the role of B7-1 expression in tumor rejection. J. Exp. Med. 182:1415.
28. Moore, M. W., F. R. Carbone, and M. J. Bevan. 1988. Introduction of soluble protein into the class I pathway of antigen processing and presentation. Cell 54:777.
29. Razi-Wolf, Z., G. Freeman, F. Galvin, B. Benacerraf, L. Nadler, and H. Reiser. 1992. Expression and function of the murine B7 antigen, the major costimulatory molecule expressed by peritoneal exudate cells. Proc. Natl. Acad. Sci. USA 89-4210.
30. Hathcock, K. S., G. Laszlo, H. B. Dickler, J. Bradshaw, P. Linsley, and R. J. Modes. 1993. Identification of an alternative CTLA-4 ligand costimulatory for T cell activation. Science 262:905.
31. Restifo, N. P., I. Bacik, K. R. Irvine, J. W. Yewdell, B. J. McCabe, R. W. Anderson, L. C. Eisenlohr, S. A. Rosenberg, and J. R. Bennink. 1995. Antigen processing in vivo and the elicitation of primary CTL responses. J. Immunol. 154:4414.
32. Reiser, H., and E. E. Schneeberger. 1996. Expression and function of B7-1 and B7-2 in hapten-induced contact sensitivity. Eur. J. Immunol. 26:880.
33. Kovacsovics-Bankowski, M., K. Clark, B. Benacerraf, and K. L. Rock. 1993. Efficient major histocompatibility complex class I presentation of exogenous antigen upon phagocytosis by macrophages. Proc. Natl. Acad. Sci. USA 90:4942.
34. Falo, L. D., Jr., M. Kovacsovics-Bankowski, K. Thompson, and K. L. Rock. 1995. Vaccination with paniculate antigen induces protective tumor immunity Nat. Med. 1:649.
35. Bachmann, M. F., E. Sebzda, T. M. Kundig, A. Shahinian, D. E. Speiser, T. W. Mak, and P. S. Ohashi. 1996. T cell responses are governed by avidity and co-stimulatory thresholds. Eur. J. Immunol. 26:2017.
36. Bluestone, J. A. 1995. New perspectives of CD28-B7-mediated T cell costimulation. Immunity 2:555.
37. Porgador, A., J. W. Yewdell, Y. Deng, J. R. Bennink, and R. N. Germain. 1997. Localization, quantitation, and in situ detection of specific peptide-MHC class I complexes using a monoclonal antibody. Immunity 6:715.
38. Gajewski, T. F., F. Fallarino, C. Uyttenhove, and T. Boon. 1996. Tumor rejection requires a CTLA4 ligand provided by the host or expressed on the tumor: superiority of B7-1 over B7-2 for active tumor immunization. J. Immunol. 156:2909.
39. + T lymphocytes in the P815 tumor system in vitro. J. Immunol. 156:465.
40. Kundig, T. M., A. Shahinian. K. Kawai, H. W. Mittrucker, E. Sebzda, M. F. Bachmann, T. W. Mak, and P. S. Ohashi. 1996. Duration of TCR stimulation determines costimulatory requirement of T cells. Immunity 5:41.
41. Harding, C. V., and R. Song. 1994. Phagocytic processing of exogenous particulate antigens by macrophages for presentation by class I MHC molecules. J. Immunol. 153:4925.
42. Kovacsovics-Bankowski, M., and K. L. Rock. 1994. Presentation of exogenous antigens by macrophages: analysis of major histocompatibility complex class I and II presentation and regulation by cytokines. Eur. J. Immunol. 24:2421.
43. Bohm, W., R. Schirmbeck, A. Elbe, K. Melber, D. Diminky, G. Kraal, N. van Rooijen, Y. Barenholz, and J. Reimann. 1995. Exogenous hepatitis B surface antigen particles processed by dendritic cells or macrophages prime murine MHC class I-restricted CTLs in vivo. J. Immunol. 155:3313.
44. Shen, Z., G. Reznikoff, G. Dranoff, and K. L. Rock. 1997. Cloned dendritic cells can present exogenous antigens on both MHC class 1 and class II molecules. J. Immunol. 158:2723.
45. Debrick, J. E., P. A. Campbell, and U. D. Staerz. 1991. Macrophages as accessory cells for class I MHC-restricted immune responses. J. Immunol. 147:2846.